Wikidata

(Q40036521)

English

p38 MAPK, but not ERK1/2, is critically involved in the cytotoxicity of the novel vascular disrupting agent combretastatin A4.

scientific article published on April 2008

In more languages

Statements

title
p38 MAPK, but not ERK1/2, is critically involved in the cytotoxicity of the novel vascular disrupting agent combretastatin A4. (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
18074350
retrieved
16 September 2017
author name string
Haitian Quan
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
18074350
retrieved
16 September 2017
Yongping Xu
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
18074350
retrieved
16 September 2017
Liguang Lou
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
18074350
retrieved
16 September 2017
publication date
1 April 2008
1 reference
stated in
Europe PubMed Central
PubMed ID
18074350
retrieved
16 September 2017
page(s)
1730-1737
1 reference
stated in
Europe PubMed Central
PubMed ID
18074350
retrieved
16 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q40036521&oldid=1481747567"